| PERIOD ENDING | 27-Dec-08 | 29-Dec-07 | 30-Dec-06 | | Total Revenue | 8,267,008 | 9,081,962 | 8,965,707 | | Cost of Revenue | 6,212,591 | 6,771,657 | 6,656,497 | | | Gross Profit | 2,054,417 | 2,310,305 | 2,309,210 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,862,555 | 1,966,134 | 2,002,965 | | Non Recurring | 2,128,063 |
-
| 146,216 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (1,936,201) | 344,171 | 160,029 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 77,442 | 114,627 | 129,058 | | Earnings Before Interest And Taxes | (1,858,759) | 458,798 | 294,960 | | Interest Expense | 113,641 | 121,271 | 123,082 | | Income Before Tax | (1,972,400) | 337,527 | 171,878 | | Income Tax Expense | (306,481) | 125,282 | 68,741 | | Minority Interest | 7,987 | (4,872) | (4,083) | | | | Net Income From Continuing Ops | (1,657,932) | 207,373 | 99,054 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (7,333) | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (1,657,932) | 207,373 | 91,721 | | Preferred Stock And Other Adjustments | (3,663) | (3,961) | (4,037) | | | Net Income Applicable To Common Shares | ($1,661,595) | $203,412 | $87,684 |
|
1.48% Nasdaq 
Income Statement
